Identification of the toxic 6mer seed consensus for human cancer cells

Monal Patel1, Elizabeth T Bartom2,3, Bidur Paudel4

  • 1Department of Medicine/Division of Hematology/Oncology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. monal.patel@northwestern.edu.

Scientific Reports
|March 25, 2022
PubMed

Insights

A novel cancer cell death mechanism, 6mer seed toxicity, utilizes specific RNA sequences to eliminate survival genes. G-rich sequences, particularly GGGGGC, show potent toxicity against human cancer cells, offering therapeutic potential.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • RNA Therapeutics

Background:

  • 6mer seed toxicity is a novel mechanism for cancer cell death.
  • This process involves the elimination of survival genes, termed Death Induced by Survival Gene Elimination (DISE).
  • It relies on small interfering RNAs (siRNAs) or short hairpin RNAs (shRNAs) with specific G-rich nucleotide compositions.

Purpose of the Study:

  • To identify the most toxic 6mer seeds for cancer cell death.
  • To elucidate the mechanism by which the most toxic seed, GGGGGC, induces cancer cell death.
  • To evaluate the therapeutic potential of siRNAs containing the GGGGGC seed.

Main Methods:

  • Arrayed screening of 4096 6mer seeds across multiple human and mouse cell lines.
  • RNA sequencing and bioinformatics analysis to identify gene targets of the GGGGGC seed.
  • Functional assays to confirm direct targeting and the impact of seed match mutations.

Main Results:

  • G-rich 6mer seeds were identified as the most toxic.
  • The GGGGGC consensus sequence was the most toxic average 6mer seed for human cancer cells.
  • siRNA containing the GGGGGC seed (siGGGGGC) targets GCCCCC seed matches in the 3' UTR of survival genes, inducing miRNA-like cell death.

Conclusions:

  • The GGGGGC seed mediates cancer cell death through targeting critical survival genes.
  • siGGGGGC exhibits miRNA-like activity, leading to cancer cell elimination.
  • Artificial miRNAs, siRNAs, or shRNAs containing the GGGGGC seed represent a promising new avenue for cancer therapeutics.